U.S. market Closed. Opens in 2 days 6 hours 22 minutes

PYXS | Pyxis Oncology, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue2.00M1.84M1.25M444.00KN/A
Gross Profit-2.00M-1.84M-1.25M-444.00KN/A
Operating Expenses82.20M123.48M69.72M12.89M2.88M
Selling, General & Admin30.83M37.35M18.66M3.85M1.66M
Research & Development49.59M86.13M51.05M9.05M1.22M
Other Operating Expenses1.78MN/A181.00KN/AN/A
Operating Income-82.20M-123.48M-69.72M-12.89M-2.88M
Other Expenses / Income8.41M2.76M-6.26M66.00K107.00K
Before Tax Income-73.79M-120.72M-75.97M-12.83M-2.77M
Income Tax Expenses1.78M-2.76M5.56M-66.00K-107.00K
Net Income-73.79M-117.95M-81.54M-12.76M-2.67M
Interest ExpensesN/A-2.76MN/AN/AN/A
Basic Shares Outstanding39.90M33.03M32.22M34.31M34.31M
Diluted Shares Outstanding39.90M33.03M32.22M34.31M34.31M
EBITDA-78.49M-123.48M-63.49M-12.43M-2.88M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-72.01M-123.48M-75.97M-12.83M-2.77M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙